isolated from the culture filtrate and mycelia of a fungal culture, Aspergillus sydowii (Bainier and Sartory) Thorn and Church var. nov. mulundensis . The structure was established by comparative GC-MSanalyses of the derivatized acid hydrolysates of deoxymulundocandin and mulundocandin as well as by the high field NMRexperiments (COSY, NOESY and DEPT).
In the course of our screening for new antibiotics from fungi, we have isolated an antifungal antibiotic, deoxymulundocandin (1) , from a fungal culture Aspergillus sydowii (Bainier and Sartory) Thorn and Church var. nov. mulundensis . Earlier we had reported the isolation and structure elucidation of a structurally related antifungal antibiotic, mulundocandin (2) , from the same strain1'2*.
Isolation and Purification of Deoxymulundocandin The microorganism was fermented in two stainless steel fermenters of 150 liters and 390 liters capacities with 95liters and 270liters of the production media as previously described1*. After 66hours the fermentation was terminated and the culture broth was centrifuged to separate the culture filtrate and the mycelial mass. Deoxymulundocandin, along with mulundocandin, was present in the culture filtrate as well as in the cell mass. The mycelial mass (33.5 kg) was extracted with acetone (2 x 100 liters). The extract was concentrated under reduced pressure to 60 liters, diluted with water and then reextracted with ethyl acetate (4 x 60liters). The culture filtrate (337liters) was extracted with ethyl acetate (245 liters), the extracts were combinedwith the mycelial extract and then concentrated under reduced pressure to obtain an oil (253 g). Trituration of the oil with acetonitrile (3 x 5liters) gave an insoluble solid. This solid was treated with methanol (2 x 1 liter) and the methanol soluble portion was concentrated to obtain the crude antibiotic (6 g). The concentrate, adsorbed on TLC grade silica gel, was loaded on to a silica gel column (TLC grade, 350 g, 3 cm x 85 cm) packed in ethyl acetate.
The elution was carried out under pressure using ethyl acetate-propanol (5 :2) followed by ethyl acetate -propanol (5 : 3). Bioactive fractions were analyzed by TLC (see Table 1 ) and fractions containing pure deoxymulundocandin were combined. Removalof solvent under reduced pressure gave the pure compound (85 mg).
Physico-chemical Properties
Deoxymulundocandin (1), is a white amorphous powder having mp 167~168°C, [a]^5 -28.23°(c 0.25, methanol), a molecular weight of 991 and a molecular formula of C48H77N7O15 (HRFAB-MSin the presence of lithium chloride gave (M +Li)+ 998.552). The compound is soluble in methanol, dimethyl sulfoxide and Af,7V-dimethylformamide, but insoluble in other common organic solvents like acetone, acetonitrile, chloroform, ethyl acetate, petroleum ether etc. and also in water. The 400MHz *H NMRspectrum is shown in Fig. 1 . The above properties indicate that the compound is an echinocandin type antibiotic-similar to mulundocandin (2).
Structure Elucidation
The acid hydrolysate of deoxymulundocandin was converted to the methyl ester which was then trifluoroacetylated.
This sample in methylene chloride was compared with a similarly prepared sample from mulundocandin by GC-MS (Fig. 2) . All the peaks in GCwere characterized by their mass spectra in the CI as well as El modes. Seven peaks (peaks A~F and peak H) were commonin the two GC runs; these were identified as derivatized amino acids namely threonine (peak A), serine (peak B), 3-hydroxy-4-methylproline (peak C), 4-hydroxyproline (peak D), 4-oxoproline (peak E, an artifact derived from 4,5-dihydroxyornithine), epimeric 4-hydroxyproline (peak F, an artifact) and 12-methyltetradecanoic acid (peak H). The two runs were different in the formation of 3 (peak I), a derivatized dehydration-decarboxylation product of 3,4-dihydroxyhomotyrosine, in the case of mulundocandin and of 4 (peak G), a derivatized 3-hydroxyhomotyrosine, in the case of deoxymulundocandin. This suggested osine which is present in mulundocandin-the rest of the structural units being identical.
The 400MHz *H NMRspectrum (DMSO-4/303K) ( Fig. 1 ) and the COSY of deoxymulundocandin identified the spin systems (Table  2 ) and were in conformity with the proposed structural units of 1. The 13C NMRspectrum of both the compounds were identical2* except for the signals from the homotyrosine residue part ( Table 3) . The NOE(NOESYspectrum) of 1 and 2 were nearly identical2* suggesting the same connectivity sequence of the fatty acid and the amino acids in the two compounds. Further, since the^^H coupling constants observed were also simlar to 22), the overall conformation of the cyclic peptide must also 
Discussion
Deoxymulundocandinis a cyclic peptide with a fatty acid side chain belonging to the echinocandin class of antifungal antibiotics.
The compound is structurally related to mulundocandin; it contains 3-hydroxyhomotyrosine unit in place of the 3,4-dihydroxyhomotyrosine unit of mulundocandin. The molecular weight and the structural formula of this antibiotic is different from any of the known echinocandin type of antibiotics and hence deoxymulundocandin is described as a new compoundof the echinocandin class.
